Abstract
The International Academy of Cytology (IAC) Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy (FNAB) Cytology reporting system is an initiative of the IAC that seeks to provide a comprehensive, standardized approach to breast FNAB reporting to facilitate reproducible cytopathology reporting and to establish best practice guidelines. The system is evidence-based, supports a structured reporting format and will aid in maximizing the usefulness of the FNAB technique and optimizing communication with the clinical team and the patient.
The use of five categories was chosen to maintain a high negative predictive value of a benign diagnosis and a high positive predictive value of a malignant diagnosis. The categories are Insufficient/Inadequate, Benign, Atypical, Suspicious of Malignancy and Malignant and stratify breast FNAB cytology by the risk of malignancy.
The role of FNAB and the technique of performing FNAB and making direct smears are presented.
The Atlas outlines the definitions for each of the categories and provides key cytological diagnostic criteria, differential diagnoses and photomicrographs for the range of specific diagnoses for each category. The Atlas addresses in detail the problem areas of atypical and suspicious of malignancy, in particular the interpretation of in situ and borderline lesions. A management chapter is included to assist in determining management for each category in a spectrum of clinical scenarios and with a range of medical resources.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ciatto S, Cariaggi P, Bulgaresi P, Confortini M, Bonardi R. Fine needle aspiration cytology of the breast: review of 9533 consecutive cases. Breast. 1993;2:87–90.
Boerner S, Fornage BD, Singletary E, Sneige N. Ultrasound-guided fine-needle aspiration (FNA) of nonpalpable breast lesions: a review of 1885 FNA cases using the National Cancer Institute-supported recommendations on the uniform approach to breast FNA. Cancer. 1999;87(1):19–24.
Bulgaresi P, Cariaggi P, Ciatto S, Houssami N. Positive predictive value of breast FNAC in combination with clinical and imaging findings: a series of 2334 subjects with abnormal cytology. Breast Cancer Res Treat. 2006;97:319–21.
Orell S, Sterrett G. Ch 7. Breast fine needle aspiration cytology. 5th ed. Edinburgh: Churchill Livingstone; 2012.
Tse G, Tan PH, Schmitt F. Fine needle aspiration cytology of the breast. Berlin: Springer; 2013.
Ducatman BS, Wang HH. Breast. In: Cibas E, Ducataman B, editors. Ch 9 in Cytology: Principles and Clinical Correlates. 4th ed. Philadelphia: Elsevier/Saunders; 2014.
Field AS. Chapter 5 Breast. In: Field AS, Zarka MR, editors. Practical Cytopathology: Pattern Recognition Diagnostic Approach. Saint Louis: Elsevier; 2016.
Chaiwun B, Settakorn J, Ya-In C, Wisedmongkol W, Rangdaeng S, Thorner P. Effectiveness of fine-needle aspiration cytology of breast: analysis of 2,375 cases from northern Thailand. Diagn Cytopathol. 2002;26(3):201–5.
Ukah CO, Oluwasola OA. The clinical effectiveness of FNAB in patients with palpable breast lesions seen at the University College Hospital, Ibadan, Nigeria: a ten year retrospective study. J Cytol. 2011;28:111–3.
Ly A, Ono JC, Hughes KS, Pitman MB, Balassanian R. FNAB of palpable breast masses: patterns of clinical use and patient experience. J Natl Compr Cancer Netw. 2016;14:527–36.
Dong J, Ly A, Arpin R, et al. Breast fine needle aspiration continues to be relevant in a large academic medical center: experience from Massachusetts General Hospital. Breast Cancer Res Treat. 2016;158:297–305.
Farras Roca JA, Tardivon A, Thibault F, et al. Diagnostic performance of ultrasound-guided fine-needle aspiration of nonpalpable breast lesions in a multidisciplinary setting: the Institut Curie’s experience. Am J Clin Pathol. 2017;147:571–9.
Hoda R, Brachtel E. IAC Yokohama system for reporting breast FNAB cytology: a review of predictive values and risks of malignancy. Acta Cytol. 2019;63:292–301.
Wong S, Rickard M, Earls P, Arnold L, Bako B, Field AS. The IAC Yokohama system for reporting breast FNAB cytology: a single institutional retrospective study of the application of the system and the impact of ROSE. Acta Cytol. 2019;63:280–91.
Montezuma D, Malheiros D, Schmitt F. Breast FNAB cytology using the newly proposed IAC Yokohama system for reporting breast cytopathology: the experience of a single institution. Acta Cytol. 2019;63:274–9.
Nguansangiam S, Jesdapatarakul S, Tangjitgamol S. Accuracy of fine needle aspiration cytology from breast masses in Thailand. Asian Pac J Cancer Prev. 2009;10(4):623–6.
Abdel-Hadi M, Abdel-Hamid GF, Abdel-Razek N, Fawzy RK. Should fine-needle aspiration cytology be the first choice diagnostic modality for assessment of all nonpalpable breast lesions? The experience of a breast cancer screening center in Alexandria Egypt. Diagn Cytopathol. 2010;38(12):880–9.
Aker F, Gumrukcu G, Onomay BC, et al. Accuracy of fine-needle aspiration cytology in the diagnosis of breast cancer a single-center retrospective study from Turkey with cytohistological correlation in 733 cases. Diagn Cytopathol. 2015;43(12):978–86.
Daramola AO, Odubanjo MO, Obiajulu FJ, Ikeri NZ, Banjo AA. Correlation between fine-needle aspiration cytology and histology for palpable breast masses in a Nigerian tertiary health institution. Int J Breast Cancer. 2015;2015:742573.
Nkonge KM, Rogena EA, Walong EO, Nkonge DK. Cytological evaluation of breast lesions in symptomatic patients presenting to Kenyatta National Hospital, Kenya: a retrospective study. BMC Womens Health. 2015;15:118.
Miskovic J, Zoric A, Radic Miskovic H, Soljic V. Diagnostic value of fine needle aspiration cytology for breast tumors. Acta Clin Croat. 2016;55(4):625–8.
Ibikunle DE, Omotayo JA, Ariyibi OO. Fine needle aspiration cytology of breast lumps with histopathologic correlation in Owo, Ondo State, Nigeria: a five-year review. Ghana Med J. 2017;51(1):1–5.
Field AS, Vielh P, Schmitt F. IAC standardized reporting of breast FNA biopsy cytology. Acta Cytol. 2017;61:3–6.
Field AS, Raymond W, Rickard M, et al. The International Academy of Cytology Yokohama system for reporting breast fine needle aspiration biopsy cytology. Acta Cytol. 2019;63:257–73.
Brown LA, Coghill SB. Fine needle aspiration cytology of the breast: factors affecting sensitivity. Cytopathology. 1991;2:67–74.
Howell LP, Gandour-Edwards R, Folkins K, Davis R, Yasmeen S, Afify A. Adequacy evaluation of fine-needle aspiration biopsy in the breast health clinic setting. Cancer Cytopathol. 2004;102:295–301.
Ljung BM, Drejet A, Chiampi N, et al. Diagnostic accuracy of FNAB is determined by physician training in sampling technique. Cancer Cytopathol. 2001;93:263–8.
Delaloge S, Bonastre J, Borget I, et al. The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic. Eur J Cancer. 2016;66:131–7.
Masood S. Diagnostic terminology in FNAB of the breast. Cancer Cytopathol. 1999;87:1–4.
Kocjan G, Feichter G, Hagmar B, et al. FNAC: a survey of current European practice. Cytopathology. 2006;17:219–26.
Field AS. Breast FNAB cytology: current problems and the IAC Yokohama standardized reporting system. Cancer Cytopathol. 2017;125:229–30.
Klijanienko J, Sauer T, Garred U, et al. Assessing invasive criteria in FNA from breast carcinoma diagnosed as DCIS or invasive carcinoma: can we identify an invasive component in addition to DCIS? Acta Cytol. 2006;50z:263–70.
Klijanienko JKS, Vielh P, Masood S. Stromal infiltration as a predictor of tumor invasion in breast fine-needle aspiration biopsy. Diagn Cytopathol. 2004;30(3):182–6.
Bonzanini M, Gilioli E, Brancato B, Cristofori A, Bricolo D, Natale N, et al. The cytopathology of ductal carcinoma in situ of the breast. A detailed analysis of fine needle aspiration cytology of 58 cases compared with 101 invasive ductal carcinomas. Cytopathology. 2001;12(2):107–19.
Sauer T, Young K, Thoresen SO. Fine needle aspiration cytology in the work-up of mammographic and ultrasonographic findings in breast cancer screening: an attempt at differentiating in situ and invasive carcinoma. Cytopathology. 2002;13(2):101–10.
Simsir A, Waisman J, Cangiarella J. Fibroadenomas with atypia: causes of under and overdiagnosis by aspiration biopsy. Diagn Cytopathol. 2001;25:278–84.
Field AS, Mak A. A prospective study of the diagnostic accuracy of cytological criteria in the FNAB diagnosis of breast papillomas. Diagn Cytopathol. 2007;35:465–75.
Silverman JF, Masood S, Ducatman BS, et al. Can FNA biopsy separate atypical hyperplasia, carcinoma in-situ, and invasive carcinoma of the breast? Cytomorphologic criteria and limitations in diagnosis. Diagn Cytopathol. 1993;24:630–5.
Bofin AM, Lydersen S, Hagmar BM. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast. Diagn Cytopathol. 2004;31:207–15.
Yu S-N, Li J, Wong S-I, et al. Atypical aspirates of the breast: a dilemma in current cytology practice. J Clin Pathol. 2017;70:1024–32.
Lieske B, Ravichandran D, Wright D. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma. Br J Cancer. 2006;95:62–6.
Wang M, He X, Chang Y, Sun G, Thabane L. A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis. Breast. 2017;31:157–66.
Kojcan G, Bourgain C, Fassina A, et al. The role of FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology. 2008;19:271–8.
Gibbons CE, Quinn CM, Gibbons D. Fine needle aspiration biopsy management of the axilla in primary breast carcinoma. Acta Cytol. 2019;63:314–8.
Boughey JC, Moriarty JP, Degnim AC, et al. Cost modelling of preoperative axillary ultrasound and FNA to guide surgery for invasive breast cancer. Ann Surg Oncol. 2010;17:953–8.
Masood S, Rosa M, Kraemer DF, Smotherman MS, Mohammadi A. Comparative cost-effectiveness of FNAB versus image-guided CNB, and open surgical biopsy in the evaluation of breast cancer in the era of the Affordable Care Act: a changing landscape. Diagn Cytopathol. 2015;43:605–12.
van Zante A, Ljung BM. Fine-needle aspiration versus core needle biopsy: Reconsidering the evidence of superiority. Cancer Cytopathol. 2016;24:853–6.
Uematsu T, Kashimi M. Risk of needle tract seeding of breast cancer: cytological results derived from core wash material. Breast Cancer Res Treat. 2008;110:51–5.
Sennerstam RB, Franzen BSH, Wiksell HOT, Auer GU. Core needle biopsy of breast cancer is associated with a higher rate of distant metastases 5 to 15 years after diagnosis than FNAB. Cancer Cytopathol. 2017;125:748–56.
Masood S, Vass L, Ibarra JA Jr. Breast pathology guideline implementation in low- and middle income countries. Cancer. 2008;113:2297–304.
Anderson BO. FNAB for breast cancer diagnosis: one size does not fit all. J Natl Compr Cancer Netw. 2016;14:599–600.
Field AS. Cytopathology in low medical infrastructure countries: how to integrate to capacitate health care, in clinics in laboratory medicine. In: Global health and pathology. Philadelphia: Elsevier; 2018.
Vohra P, Buelow B, Chen YY, et al. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: a large retrospective study. Cancer Cytopathol. 2016;124:828–35.
Beca F, Schmitt FC. Ancillary tests in breast cytology; a practical review. Acta Cytol. 2019;63:302–13.
Field AS, Geddie WR. Ch 1 and 2, in Lymph node and spleen Cytohistology. Cambridge: Cambridge University Press; 2014.
Ljung BM. https://www.youtube.com/watch?v=nWhB6WhX9AQ&list=PLaWBzZZDQvpecETKjD7_gupwB34tlcOWZ. Last accessed Mar 2019.
Gerhard R, Schmitt FC. Liquid-based cytology in fine-needle aspiration of breast lesions: a review. Acta Cytol. 2014;58:533–42.
Istvanic SI, Fischer AH, Banner BF, et al. Cell blocks of breast FNAB frequently allow diagnosis of invasion or histological classification of proliferative changes. Diagn Cytopathol. 2007 May;35(5):263–9.
Williams SL, Birdsong GG, Cohen C, Siddiqui MT. Immunohistochemical detection of estrogen and progesterone receptor and HER2 expression in breast carcinomas: comparison of cell block and tissue block preparations. Int J Clin Exp Pathol. 2009;2(5):476–80.
Ferguson J, Chamberlain P, Cramer HM, Wu HH. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies. Diagn Cytopathol. 2013;41(7):575–81.
Ellis DW, Srigley J. Does standardised structured reporting contribute to quality in diagnostic pathology? The importance of evidence-based data sets. Virchows Arch. 2016;468:51–9.
Royal College of Australasia. Structured pathology reporting of cancer. https://www.rcpa.edu.au/Health-Care. Accessed Feb 2019.
International Confederation Cancer Reporting (ICCR). https://www.iccr-cancer.org. Accessed Feb 2019.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Field, A.S. et al. (2020). The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: Introduction and Overview. In: Field, A.S., Raymond, W.A., Schmitt, F. (eds) The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology. Springer, Cham. https://doi.org/10.1007/978-3-030-26883-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-26883-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26882-4
Online ISBN: 978-3-030-26883-1
eBook Packages: MedicineMedicine (R0)